During the past decade, Blis Technologies Ltd conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Blis Technologies Ltd" are "Microbial Colonization" (5 trials), "Lower Respiratory Tract Infection" (1 trials) and "Upper Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "Blis Technologies Ltd" in a lesser frequency.

Most popular intervention types in "Blis Technologies Ltd" are "Dietary Supplement" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Probiotic S. salivarius K12 lozenges containing prebiotic A" (1 trials), "Probiotic S. salivarius K12 lozenges containing prebiotic B" (1 trials), "Probiotic S. salivarius K12 lozenges containing prebiotics A and B" (1 trials), "Probiotic S. salivarius K12 powder" (1 trials) and "Probiotic S. salivarius K12 powder containing prebiotic A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blis Technologies Ltd" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Blis Technologies Ltd". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Blis Technologies Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blis Technologies Ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".